Who To Contact

Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207

Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com

Clinical Trial ID: NCT05324501

PHASE 1 OPEN LABEL ASCENDING DOSE STUDY TO ASSESS THE FEASIBILITY AND SAFETY OF INTERMITTENT INFUSIONS OF MTX110 ADMINISTERED BY CONVECTION-ENHANCED DELIVERY (CED) AS A MONOTHERAPY OR IN COMBINATION WITH LOMUSTINE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM) (MAGIC-G1 STUDY)

Status

Open

Conditions

Other

Phases

1

Age Group

Adult

Main Investiagtor

Cavaliere, Robert

Practice

CNS

Scope

National

Participating Institutions

Baptist MD Anderson Cancer Center

Nct ID Number

NCT05324501

Secondary Trial ID Number

MTX110-102

Keywords

Treatment